======= SLC25A36 ======= == Gene Information == * **Official Symbol**: SLC25A36 * **Official Name**: solute carrier family 25 member 36 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55186|55186]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96CQ1|Q96CQ1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC25A36&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC25A36|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616149|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Mitochondrial transporter that imports/exports pyrimidine nucleotides into and from mitochondria. Transports preferentially cytosine and uracil (deoxy)nucleoside mono-, di-, and triphosphates by uniport and antiport mechanism. Also transports guanine but not adenine (deoxy)nucleotides. Is inhibited strongly by pyridoxal 5'-phosphate, 4,7-diphenyl-1,10- phenanthroline, tannic acid, and mercurials (mercury dichloride, Mersalyl acid, p-hydroxymercuribenzoate). Participates in mitochondrial genome maintenance, regulation of mitochondrial membrane potential and mitochondrial respiration. {ECO:0000269|PubMed:25320081}. |Mito carr| |pyrimidine nucleotide transmembrane transporter activity| |pyrimidine nucleotide import into mitochondrion| |pyrimidine nucleotide transport| |nucleotide transmembrane transport| |pyrimidine-containing compound transmembrane transport| |mitochondrial genome maintenance| |nucleotide transport| |regulation of mitochondrial membrane potential| |mitochondrial transmembrane transport| |organophosphate ester transport| |mitochondrial transport| |nucleobase-containing compound transport| |mitochondrial inner membrane| |regulation of membrane potential| |mitochondrion organization| |mitochondrion| |transmembrane transport| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.14| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.83| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-1.77| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|1.72| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|1.78| |[[:results:exp246|UM0011500 10μM R05 exp246]]|1.95| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|2.03| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|2.39| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|3.97| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|4.16| ^Gene^Correlation^ |[[:human genes:m:mrs2|MRS2]]|0.543| |[[:human genes:p:prim1|PRIM1]]|0.502| |[[:human genes:c:cox7a2l|COX7A2L]]|0.484| |[[:human genes:p:polr2j3|POLR2J3]]|0.469| |[[:human genes:s:slc25a33|SLC25A33]]|0.446| |[[:human genes:m:mgme1|MGME1]]|0.442| |[[:human genes:s:syt9|SYT9]]|0.431| |[[:human genes:t:tbc1d3g|TBC1D3G]]|0.401| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 19026 * **Expression level (log2 read counts)**: 6.9 {{:chemogenomics:nalm6 dist.png?nolink |}}